These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16514157)

  • 1. The encapsulation of enterotoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration.
    Byrd W; Cassels FJ
    Microbiology (Reading); 2006 Mar; 152(Pt 3):779-786. PubMed ID: 16514157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres.
    Byrd W; Cassels FJ
    Vaccine; 2006 Feb; 24(9):1359-66. PubMed ID: 16233937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term systemic and mucosal antibody responses measured in BALB/c mice following intranasal challenge with viable enterotoxigenic Escherichia coli.
    Byrd W; Cassels FJ
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):262-8. PubMed ID: 16487308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.
    Jones FR; Hall ER; Tribble D; Savarino SJ; Cassels FJ; Porter C; Meza R; Nunez G; Espinoza N; Salazar M; Luckett R; Scott D
    Vaccine; 2006 May; 24(18):3786-92. PubMed ID: 16343702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin.
    Byrd W; Cassels FJ
    Vaccine; 2003 May; 21(17-18):1884-93. PubMed ID: 12706673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
    Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
    Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers.
    Carpenter CM; Hall ER; Randall R; McKenzie R; Cassels F; Diaz N; Thomas N; Bedford P; Darsley M; Gewert C; Howard C; Sack RB; Sack DA; Chang HS; Gomes G; Bourgeois AL
    Vaccine; 2006 May; 24(18):3709-18. PubMed ID: 16153753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c mice.
    Shekar A; Ramlal S; Jeyabalaji JK; Sripathy MH
    Med Microbiol Immunol; 2019 Feb; 208(1):89-100. PubMed ID: 30209565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6.
    de Lorimier AJ; Byrd W; Hall ER; Vaughan WM; Tang D; Roberts ZJ; McQueen CE; Cassels FJ
    Vaccine; 2003 Jun; 21(19-20):2548-55. PubMed ID: 12744890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
    Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
    Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli.
    Nazarian S; Gargari SL; Rasooli I; Hasannia S; Pirooznia N
    Microbiol Res; 2014; 169(2-3):205-12. PubMed ID: 23906742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
    Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of thiolated eudragit microspheres as an oral vaccine delivery system to induce mucosal immunity against enterotoxigenic Escherichia coli in mice.
    Lee WJ; Cha S; Shin M; Jung M; Islam MA; Cho CS; Yoo HS
    Eur J Pharm Biopharm; 2012 May; 81(1):43-8. PubMed ID: 22306699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
    Eldridge JH; Staas JK; Meulbroek JA; Tice TR; Gilley RM
    Infect Immun; 1991 Sep; 59(9):2978-86. PubMed ID: 1879922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.
    McKenzie R; Bourgeois AL; Engstrom F; Hall E; Chang HS; Gomes JG; Kyle JL; Cassels F; Turner AK; Randall R; Darsley M; Lee C; Bedford P; Shimko J; Sack DA
    Infect Immun; 2006 Feb; 74(2):994-1000. PubMed ID: 16428745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens.
    Fattal E; Pecquet S; Couvreur P; Andremont A
    Int J Pharm; 2002 Aug; 242(1-2):15-24. PubMed ID: 12176221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
    Qadri F; Akhtar M; Bhuiyan TR; Chowdhury MI; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Lundgren A; Wiklund G; Kaim J; Löfstrand M; Carlin N; Bourgeois AL; Maier N; Fix A; Wierzba T; Walker RI; Svennerholm AM
    Lancet Infect Dis; 2020 Feb; 20(2):208-219. PubMed ID: 31757774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.